226 related articles for article (PubMed ID: 9550652)
1. Expression of inducible lymphocyte costimulatory molecules in human renal allograft.
Biancone L; Segoloni G; Turello E; Donati D; Bussolati B; Piccoli G; Camussi G
Nephrol Dial Transplant; 1998 Mar; 13(3):716-22. PubMed ID: 9550652
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of costimulatory molecules in chronic inflammatory periodontal disease tissue.
Orima K; Yamazaki K; Aoyagi T; Hara K
Clin Exp Immunol; 1999 Jan; 115(1):153-60. PubMed ID: 9933436
[TBL] [Abstract][Full Text] [Related]
3. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
[TBL] [Abstract][Full Text] [Related]
4. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant.
Minguela A; Marín L; Torío A; Muro M; García-Alonso AM; Moya-Quiles MR; Sánchez-Bueno F; Parrilla P; Alvarez-López MR
Hum Immunol; 2000 Jul; 61(7):658-69. PubMed ID: 10880736
[TBL] [Abstract][Full Text] [Related]
5. CD40L, CD28, and CTLA-4 expression on CD4+ T cells in kidney graft recipients: a relationship with post-transplantation clinical course.
Kosmaczewska A; Magott-Procelewska M; Frydecka I; Ciszak L; Bocko D; Szteblich A; Kusnierczyk P; Patrzalek D; Szyber P; Klinger M
Transpl Immunol; 2006 Jun; 16(1):32-40. PubMed ID: 16701174
[TBL] [Abstract][Full Text] [Related]
6. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.
Hancock WW; Sayegh MH; Zheng XG; Peach R; Linsley PS; Turka LA
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13967-72. PubMed ID: 8943044
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease.
Battaglia E; Biancone L; Resegotti A; Emanuelli G; Fronda GR; Camussi G
Am J Gastroenterol; 1999 Nov; 94(11):3279-84. PubMed ID: 10566730
[TBL] [Abstract][Full Text] [Related]
8. Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice.
Villegas EN; Wille U; Craig L; Linsley PS; Rennick DM; Peach R; Hunter CA
Infect Immun; 2000 May; 68(5):2837-44. PubMed ID: 10768980
[TBL] [Abstract][Full Text] [Related]
9. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
Gao D; Li J; Orosz CG; Bumgardner GL
Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
[TBL] [Abstract][Full Text] [Related]
10. Construction and expression in the yeast Pichia pastoris of functionally active soluble forms of the human costimulatory molecules B7-1 and B7-2 and the B7 counter-receptor CTLA-4.
Gerstmayer B; Pessara U; Wels W
FEBS Lett; 1997 Apr; 407(1):63-8. PubMed ID: 9141482
[TBL] [Abstract][Full Text] [Related]
11. Cutting edge: the relative distribution of T cells responding to chemically dominant or minor epitopes of lysozyme is not affected by CD40-CD40 ligand and B7-CD28-CTLA-4 costimulatory pathways.
DiPaolo RJ; Unanue ER
J Immunol; 2002 Sep; 169(6):2832-6. PubMed ID: 12218093
[TBL] [Abstract][Full Text] [Related]
12. Study of lymphocyte costimulatory molecules in renal transplantation.
Biancone L; Donati D; Segoloni G; Turello E; Squiccimarro G; Bussolati B; Cantaluppi V; Amann F; Gastaldi L; Piccoli G; Camussi G
Transplant Proc; 1998 Aug; 30(5):2384-6. PubMed ID: 9723512
[No Abstract] [Full Text] [Related]
13. The role of CD40 ligand in costimulation and T-cell activation.
Grewal IS; Flavell RA
Immunol Rev; 1996 Oct; 153():85-106. PubMed ID: 9010720
[TBL] [Abstract][Full Text] [Related]
14. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
Azuma H; Chandraker A; Nadeau K; Hancock WW; Carpenter CB; Tilney NL; Sayegh MH
Proc Natl Acad Sci U S A; 1996 Oct; 93(22):12439-44. PubMed ID: 8901600
[TBL] [Abstract][Full Text] [Related]
15. Localization in situ of the co-stimulatory molecules B7.1, B7.2, CD40 and their ligands in normal human lymphoid tissue.
Vyth-Dreese FA; Dellemijn TA; Majoor D; de Jong D
Eur J Immunol; 1995 Nov; 25(11):3023-9. PubMed ID: 7489738
[TBL] [Abstract][Full Text] [Related]
16. Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4(+) T cells.
Eck SC; Turka LA
Cancer Immunol Immunother; 1999 Sep; 48(6):336-41. PubMed ID: 10473809
[TBL] [Abstract][Full Text] [Related]
17. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.
Kim KS; Denton MD; Chandraker A; Knoflach A; Milord R; Waaga AM; Turka LA; Russell ME; Peach R; Sayegh MH
Am J Pathol; 2001 Mar; 158(3):977-86. PubMed ID: 11238045
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies.
Lenschow DJ; Zeng Y; Hathcock KS; Zuckerman LA; Freeman G; Thistlethwaite JR; Gray GS; Hodes RJ; Bluestone JA
Transplantation; 1995 Nov; 60(10):1171-8. PubMed ID: 7482727
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of CD28-B7 T-cell costimulatory activation pathway affects intragraft cytokine and growth factor expression in chronic renal allograft rejection.
Nadeau K; Azuma H; Chandraker A; Sayegh MH; Tilney NL
Transplant Proc; 1997; 29(1-2):1038. PubMed ID: 9123187
[No Abstract] [Full Text] [Related]
20. Role of tolerogen conformation in induction of oral tolerance in experimental autoimmune myasthenia gravis.
Im SH; Barchan D; Souroujon MC; Fuchs S
J Immunol; 2000 Oct; 165(7):3599-605. PubMed ID: 11034361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]